Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.25% | – |
MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.25% | – |
KTWO | Exit | K2M GROUP HLDGS INC | $0 | – | -25,000 | -100.0% | -0.31% | – |
OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.31% | – |
SCYX | Exit | SCYNEXIS INC | $0 | – | -400,000 | -100.0% | -0.35% | – |
AFMD | Exit | AFFIMED N V | $0 | – | -300,000 | -100.0% | -0.36% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -30,000 | -100.0% | -0.44% | – |
ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.47% | – |
ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.48% | – |
DERM | Exit | DERMIRA INC | $0 | – | -100,000 | -100.0% | -0.53% | – |
SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.53% | – |
SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -17,500 | -100.0% | -0.60% | – |
KURA | Exit | KURA ONCOLOGY INC | $0 | – | -50,000 | -100.0% | -0.62% | – |
XNCR | Exit | XENCOR INC | $0 | – | -35,000 | -100.0% | -0.69% | – |
CERN | Exit | CERNER CORP | $0 | – | -20,000 | -100.0% | -0.76% | – |
ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
CTLT | Exit | CATALENT INC | $0 | – | -30,000 | -100.0% | -0.81% | – |
INCY | Exit | INCYTE CORP | $0 | – | -15,000 | -100.0% | -0.82% | – |
CORI | Exit | CORIUM INTL INC | $0 | – | -110,000 | -100.0% | -0.83% | – |
AKAOQ | Exit | ACHAOGEN INC | $0 | – | -100,000 | -100.0% | -0.85% | – |
VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.86% | – |
MRUS | Exit | MERUS N V | $0 | – | -75,000 | -100.0% | -0.91% | – |
ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -200,000 | -100.0% | -0.95% | – |
VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -1.08% | – |
KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.10% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -55,000 | -100.0% | -1.11% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.11% | – |
CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -65,000 | -100.0% | -1.22% | – |
MYOK | Exit | MYOKARDIA INC | $0 | – | -40,000 | -100.0% | -1.28% | – |
DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -100,000 | -100.0% | -1.33% | – |
SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -1.36% | – |
Exit | SPDR SERIES TRUSTput | $0 | – | -25,000 | -100.0% | -1.44% | – | |
ARMO | Exit | ARMO BIOSCIENCES INC | $0 | – | -60,000 | -100.0% | -1.48% | – |
MDCO | Exit | MEDICINES CO | $0 | – | -70,000 | -100.0% | -1.52% | – |
GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -60,000 | -100.0% | -1.54% | – |
RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -1.54% | – |
SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.56% | – |
ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -500,000 | -100.0% | -1.66% | – |
TSRO | Exit | TESARO INC | $0 | – | -45,000 | -100.0% | -1.69% | – |
CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -1.70% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -35,000 | -100.0% | -1.71% | – |
ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -600,000 | -100.0% | -1.82% | – |
LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -17,500 | -100.0% | -1.86% | – |
ABT | Exit | ABBOTT LABS | $0 | – | -50,000 | -100.0% | -1.97% | – |
RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -60,000 | -100.0% | -2.01% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -27,500 | -100.0% | -2.02% | – |
BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -2.08% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -30,000 | -100.0% | -2.11% | – |
MYL | Exit | MYLAN N V | $0 | – | -80,000 | -100.0% | -2.17% | – |
CI | Exit | CIGNA CORPORATION | $0 | – | -20,000 | -100.0% | -2.21% | – |
ANAB | Exit | ANAPTYSBIO INC | $0 | – | -32,500 | -100.0% | -2.22% | – |
Exit | ESPERION THERAPEUTICS INC NEput | $0 | – | -50,000 | -100.0% | -2.38% | – | |
CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -70,000 | -100.0% | -2.43% | – |
SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -25,000 | -100.0% | -2.46% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -2.60% | – |
MRK | Exit | MERCK & CO INC | $0 | – | -80,000 | -100.0% | -2.87% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -17,500 | -100.0% | -3.15% | – |
HUM | Exit | HUMANA INC | $0 | – | -20,000 | -100.0% | -3.54% | – |
GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -115,000 | -100.0% | -3.65% | – |
IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -400,000 | -100.0% | -3.84% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -100,000 | -100.0% | -4.76% | – |
Exit | SPDR S&P 500 ETF TRput | $0 | – | -50,000 | -100.0% | -8.66% | – |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOGEN INC | 17 | Q1 2018 | 7.5% |
ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
CELGENE CORP | 15 | Q4 2017 | 7.9% |
AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
DERMIRA INC | 14 | Q1 2018 | 2.7% |
AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-05-15 |
13F-HR | 2018-02-14 |
13F-HR/A | 2017-11-16 |
13F-HR | 2017-11-14 |
13F-HR | 2017-08-14 |
13F-HR | 2017-05-15 |
13F-HR | 2017-02-14 |
13F-HR/A | 2016-11-17 |
13F-HR | 2016-11-14 |
13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.